ANSYS, Inc. (ANSS) Shares Sold by Segall Bryant & Hamill LLC

Segall Bryant & Hamill LLC decreased its stake in shares of ANSYS, Inc. (NASDAQ:ANSS) by 4.9% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 10,628 shares of the software maker’s stock after selling 550 shares during the period. Segall Bryant & Hamill LLC’s holdings in ANSYS were worth $1,569,000 at the end of the most recent reporting period.

Other institutional investors also recently modified their holdings of the company. Cerebellum GP LLC bought a new position in ANSYS during the fourth quarter valued at approximately $122,000. Calton & Associates Inc. bought a new position in ANSYS during the fourth quarter valued at approximately $184,000. Advisor Partners LLC bought a new position in ANSYS during the fourth quarter valued at approximately $219,000. Conning Inc. bought a new position in ANSYS in the fourth quarter worth approximately $204,000. Finally, Diversified Trust Co bought a new position in ANSYS in the fourth quarter worth approximately $210,000. Institutional investors own 96.50% of the company’s stock.

How to Become a New Pot Stock Millionaire

Shares of ANSS stock opened at $157.74 on Friday. The stock has a market cap of $13,621.55, a price-to-earnings ratio of 52.76 and a beta of 1.04. ANSYS, Inc. has a 52 week low of $104.55 and a 52 week high of $171.92.

ANSYS (NASDAQ:ANSS) last announced its quarterly earnings data on Wednesday, February 21st. The software maker reported $1.07 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $1.03 by $0.04. The firm had revenue of $302.34 million during the quarter, compared to analysts’ expectations of $290.66 million. ANSYS had a net margin of 23.67% and a return on equity of 13.77%. The company’s revenue for the quarter was up 11.7% compared to the same quarter last year. During the same period in the prior year, the company posted $0.98 earnings per share. analysts anticipate that ANSYS, Inc. will post 4.41 EPS for the current fiscal year.

ANSYS announced that its Board of Directors has initiated a share buyback program on Wednesday, February 21st that permits the company to repurchase 5,000,000 shares. This repurchase authorization permits the software maker to repurchase shares of its stock through open market purchases. Shares repurchase programs are typically an indication that the company’s board of directors believes its stock is undervalued.

Several research firms have weighed in on ANSS. BidaskClub upgraded shares of ANSYS from a “buy” rating to a “strong-buy” rating in a research report on Saturday, March 10th. Wedbush reiterated a “neutral” rating and issued a $136.00 price target (down from $160.00) on shares of ANSYS in a research report on Friday, February 23rd. Berenberg Bank upgraded shares of ANSYS from a “hold” rating to a “buy” rating and set a $123.00 price target on the stock in a research report on Tuesday, January 30th. Zacks Investment Research upgraded shares of ANSYS from a “hold” rating to a “buy” rating and set a $181.00 price target on the stock in a research report on Wednesday, February 28th. Finally, ValuEngine upgraded shares of ANSYS from a “hold” rating to a “buy” rating in a research report on Thursday, March 1st. Two research analysts have rated the stock with a sell rating, nine have assigned a hold rating, four have issued a buy rating and one has issued a strong buy rating to the stock. The stock currently has an average rating of “Hold” and an average price target of $132.00.

In other news, VP Richard S. Mahoney sold 8,527 shares of the stock in a transaction on Tuesday, January 2nd. The shares were sold at an average price of $17.84, for a total value of $152,121.68. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, VP Richard S. Mahoney sold 1,625 shares of the stock in a transaction on Wednesday, March 7th. The stock was sold at an average price of $161.90, for a total transaction of $263,087.50. The disclosure for this sale can be found here. Over the last three months, insiders sold 61,691 shares of company stock valued at $8,852,518. Corporate insiders own 1.30% of the company’s stock.

COPYRIGHT VIOLATION NOTICE: This piece was originally posted by Ticker Report and is the property of of Ticker Report. If you are viewing this piece on another publication, it was illegally stolen and republished in violation of US and international copyright & trademark legislation. The correct version of this piece can be read at https://www.tickerreport.com/banking-finance/3297098/ansys-inc-anss-shares-sold-by-segall-bryant-hamill-llc.html.

ANSYS Company Profile

ANSYS, Inc (ANSYS) develops and markets engineering simulation software and services used by engineers, designers, researchers and students across a range of industries and academia, including aerospace and defense, automotive, industrial equipment, electronics, biomedical, energy, materials and chemical processing, and semiconductors.

Want to see what other hedge funds are holding ANSS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for ANSYS, Inc. (NASDAQ:ANSS).

Institutional Ownership by Quarter for ANSYS (NASDAQ:ANSS)

Receive News & Ratings for ANSYS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ANSYS and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Zacks: Brokerages Expect Spark Therapeutics  Will Announce Quarterly Sales of $53.82 Million
Zacks: Brokerages Expect Spark Therapeutics Will Announce Quarterly Sales of $53.82 Million
USDe  Price Hits $0.0002 on Exchanges
USDe Price Hits $0.0002 on Exchanges
DigiPulse  Reaches 24 Hour Trading Volume of $211,967.00
DigiPulse Reaches 24 Hour Trading Volume of $211,967.00
1337 Price Reaches $0.0005
1337 Price Reaches $0.0005
Nicolet Bankshares  Receives $61.25 Average Target Price from Analysts
Nicolet Bankshares Receives $61.25 Average Target Price from Analysts
Marinus Pharmaceuticals, Inc.  Receives $18.75 Average Target Price from Analysts
Marinus Pharmaceuticals, Inc. Receives $18.75 Average Target Price from Analysts


© 2006-2018 Ticker Report. Google+.